CN117646040A - Method for converting xylose mother liquor into xylitol through biological fermentation - Google Patents
Method for converting xylose mother liquor into xylitol through biological fermentation Download PDFInfo
- Publication number
- CN117646040A CN117646040A CN202311681748.8A CN202311681748A CN117646040A CN 117646040 A CN117646040 A CN 117646040A CN 202311681748 A CN202311681748 A CN 202311681748A CN 117646040 A CN117646040 A CN 117646040A
- Authority
- CN
- China
- Prior art keywords
- xylitol
- mother liquor
- fermentation
- xylose mother
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 title claims abstract description 148
- 238000000855 fermentation Methods 0.000 title claims abstract description 87
- 230000004151 fermentation Effects 0.000 title claims abstract description 87
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 title claims abstract description 86
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 title claims abstract description 86
- 239000000811 xylitol Substances 0.000 title claims abstract description 86
- 235000010447 xylitol Nutrition 0.000 title claims abstract description 86
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 title claims abstract description 86
- 229960002675 xylitol Drugs 0.000 title claims abstract description 86
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 title claims abstract description 75
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 239000012452 mother liquor Substances 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000012216 screening Methods 0.000 claims abstract description 24
- 230000000694 effects Effects 0.000 claims abstract description 20
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims abstract description 18
- 235000018368 Saccharomyces fragilis Nutrition 0.000 claims abstract description 18
- 229940031154 kluyveromyces marxianus Drugs 0.000 claims abstract description 18
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 15
- 238000002703 mutagenesis Methods 0.000 claims abstract description 15
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 230000000241 respiratory effect Effects 0.000 claims abstract description 11
- 239000000654 additive Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 25
- 239000002609 medium Substances 0.000 claims description 23
- 239000001963 growth medium Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 244000253911 Saccharomyces fragilis Species 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 14
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 claims description 12
- 240000008042 Zea mays Species 0.000 claims description 12
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 12
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 12
- 230000004913 activation Effects 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 235000005822 corn Nutrition 0.000 claims description 12
- 238000004043 dyeing Methods 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 10
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 239000007640 basal medium Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 16
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 4
- 238000007447 staining method Methods 0.000 abstract description 4
- 201000004569 Blindness Diseases 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241000235650 Kluyveromyces marxianus Species 0.000 abstract 1
- 235000000053 special nutrition Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229950006238 nadide Drugs 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 108700040099 Xylose isomerases Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- -1 hydrogen ions Chemical class 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of xylitol preparation and biological fermentation, and particularly relates to a method for converting xylose mother liquor into xylitol through biological fermentation. According to the method for converting xylose mother liquor into xylitol through biological fermentation, kluyveromyces marxianus is used as a fermentation strain, and nitrosoguanidine is used for carrying out mutagenesis on the strain to obtain a base mutant strain; then, a TC staining method is adopted for screening to obtain strains with vigorous respiratory enzyme activity, so that blindness of common screening is reduced; and finally, according to the way of converting xylose into xylitol, special nutrition additives are added, so that the conversion of xylose into xylitol can be further promoted. The method not only omits the xylose purification step, but also simplifies the xylitol separation step, can effectively reduce the production cost of the xylitol, and has high content and purity of the xylitol in the obtained product, thereby having good application prospects in the fields of reuse of xylose mother liquor and production of the xylitol.
Description
Technical Field
The invention belongs to the technical field of xylitol preparation and biological fermentation, and particularly relates to a method for converting xylose mother liquor into xylitol through biological fermentation.
Background
Xylitol is a polyhydric alcohol containing five carbon atoms and five hydroxyl groups, and has wide application in industries such as food, medicine, paper making, chemical industry and the like. The current industrial method for preparing xylitol mainly comprises the following steps: xylose is obtained by acid hydrolysis of xylan, and xylitol is prepared by a chemical catalytic hydrogenation method. In the xylose extraction process, a great amount of xylose mother liquor byproducts are generated. The xylose mother liquor is brown yellow, contains more impurities, has low purity and high viscosity, and contains glucose, galactose, arabinose and other carbon sources with certain concentration and a small amount of furfural, tetrahydrofuran and other substances besides xylose.
In order to avoid resource waste and realize the reutilization of xylose mother liquor, many researchers have studied on the utilization and the reextraction technology of xylose mother liquor. The most common existing purification process is to decompress and evaporate xylose mother liquor, and then filter out evaporated xylose crystals. However, this method has problems of high energy consumption, unstable quality, and high water content of the crystals obtained. In addition, a scholars sequentially propose a process method for separating and purifying the xylose mother liquor by using resin and a process method for separating active ingredients in the xylitol mother liquor by using chromatography. The separation method needs to carry out procedures such as concentration and separation on xylose in mother liquor, and then carries out a series of operations such as filtration and exchange again to obtain xylitol, and has the problems of high equipment requirement and high operation difficulty. Later, some researchers propose a method for fermenting xylose mother liquor by using strains, which adopts the strains to directly ferment xylose in the xylose mother liquor into xylitol, but the problems of longer fermentation period and lower conversion rate still exist, so that the further application of the method is limited.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a method for converting xylose mother liquor into xylitol through biological fermentation, which comprehensively improves the conditions and the formula from strain breeding to fermentation, and can greatly improve the yield and the purity of the xylitol
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
a method for converting xylose mother liquor to xylitol by biological fermentation, comprising the steps of:
(1) Carrying out chemical mutagenesis treatment on Kluyveromyces marxianus by adopting nitrosoguanidine to obtain a mutagenized strain;
(2) Dyeing the strain subjected to mutagenesis in the step (1) by adopting 2,3, 5-triphenyltetrazolium chloride, and screening according to a dyeing result to obtain a colony with vigorous respiratory enzyme activity;
(3) Respectively inoculating the colonies with vigorous respiratory enzyme activity obtained in the step (2) into a screening culture medium containing xylose mother liquor for culture, measuring the xylitol content and purity in the obtained fermentation liquor after fermentation, and screening according to the content and purity measurement results to obtain the optimal strain;
(4) And (3) inoculating the optimal strain obtained by screening in the step (3) into a fermentation culture medium containing xylose mother liquor for fermentation culture, and thus, converting the xylose mother liquor into xylitol.
As a further preferable scheme, in the step (1), the chemical mutagenesis treatment is to add 0.8-1.2 mg/mL nitrosoguanidine solution into the yeast suspension of Kluyveromyces marxianus and treat the yeast suspension in a water bath at 35-40 ℃ for 20-40 min. Nitrosoguanidine mutagenesis mainly causes GC- & gtAT conversion in the replication region of the DNA strand, and causes high-frequency mutation in microorganisms.
As a further preferable mode, in the step (1), the kluyveromyces marxianus is subjected to an activation treatment in advance; the activation treatment is to inoculate Kluyveromyces marxianus into an activation culture medium, and perform activation culture for 10-15 h at the temperature of 28-32 ℃ at 200-300 rpm; the composition of the activation medium is as follows: glucose 9-12 g, yeast extract 0.3-0.7 g, peptone 0.3-0.5 g, and water to constant volume to 50mL.
As a further preferable scheme, in the step (2), the dyeing treatment is performed after mixing the 2,3, 5-triphenyltetrazolium chloride aqueous solution with the bacterial suspension of the mutagenized strain; the dyeing treatment time is 1-3 d; the mass concentration of the 2,3, 5-triphenyl tetrazolium chloride aqueous solution is 0.8% -1.2%. In the invention, 2,3, 5-Triphenyl Tetrazolium Chloride (TTC) developer is utilized for dyeing reaction, which is called TC dyeing method, is generally used for identifying the activity of plant seeds, and can also generate color reaction on the metabolic products of yeast, and the activity of respiratory enzymes in the yeast is judged according to the color development degree. The invention uses nitrosoguanidine to carry out chemical mutagenesis treatment on the Kluyveromyces marxianus strain, and then screens the Kluyveromyces marxianus strain by TC staining method, so that the xylitol production capacity of the yeast can be distinguished, and blind screening is avoided.
As a further preferred scheme, in the step (3), the screening culture medium consists of the following components in parts by mass: 16 to 20 percent of xylose mother liquor, 0.3 to 0.8 percent of corn steep liquor dry powder, 0.03 to 0.08 percent of monopotassium phosphate and water as solvent. When the screening culture medium is prepared, 16-20 g of xylose mother liquor, 0.3-0.8 g of corn steep liquor dry powder and 0.03-0.08 g of monopotassium phosphate are taken, and water is added to fix the volume to 100mL.
As a further preferable embodiment, in step (3), the culturing conditions are: culturing at 200-300 rpm and 28-33 deg.c for 70-80 hr.
As a further preferred embodiment, in step (4), the fermentation medium consists of a basal medium and a nutritional supplement; the basic culture medium consists of the following components in parts by mass: 23 to 28 percent of xylose mother liquor, 0.3 to 0.8 percent of corn steep liquor dry powder, 0.4 to 0.6 percent of urea, 0.02 to 0.05 percent of monopotassium phosphate and water as solvent; the composition of the nutritional supplement, based on the final concentration in the basal medium, is: amino acid mixed solution 4-6 mL/L, VB 2 8~12mg/L、VB 3 4~6mg/L。
Based on the consideration of further improving the yield and purity of xylitol, as a more preferable scheme, the basal medium consists of the following components in parts by mass: 25% of xylose mother liquor, 0.5% of corn steep liquor dry powder, 0.5% of urea and 0.025% of monopotassium phosphate, and the solvent is waterThe method comprises the steps of carrying out a first treatment on the surface of the The composition of the nutritional supplement, based on the final concentration in the basal medium, is: amino acid mixture 5mL/L, VB 2 10mg/L、VB 3 5mg/L。
As a further preferable mode, in the step (4), the conditions of the fermentation culture are: fermenting and culturing at 200-300 rpm, 28-33 deg.c and pH of 5.5-6.5 for 70-80 hr.
As a further preferable mode, in the step (4), the inoculation amount of the optimal strain is 13-17% V/V during the fermentation culture.
The technical scheme of the invention has the beneficial effects that:
according to the method for converting xylose mother liquor into xylitol through biological fermentation, kluyveromyces marxianus is used as a fermentation strain, and nitrosoguanidine is used for carrying out mutagenesis on the strain to obtain a base mutant strain; then, a TC staining method is adopted for screening to obtain strains with vigorous respiratory enzyme activity, so that blindness of common screening is reduced; finally, according to the way of converting xylose into xylitol, the amino acid mixture and vitamins are added, so that the conversion of xylose into xylitol is further promoted.
According to the method disclosed by the invention, the xylitol is produced by fermenting the rough xylose mother liquor serving as a substrate by utilizing the reductase in the microorganism, so that not only is the xylose purification step omitted, but also the xylitol separation step is simplified, and the production cost of the xylitol can be effectively reduced. In addition, the xylitol is produced by adopting a biotechnology, xylose is reduced into xylitol under the catalysis of xylose reductase in microbial cells, hydrogen is derived from hydrogen atoms in reduced coenzyme in the cells and hydrogen ions in water, independent hydrogen production is not needed, and no additional hydrogen source is needed, so that the production process is simple, safe and energy-saving, and the method is a very promising production method and has good application prospects in the fields of reuse of xylose mother liquor and production of xylitol.
Detailed Description
The technical scheme of the invention will be clearly and completely described below with reference to specific examples and test examples. It should be understood by those skilled in the art that the examples are only for illustrating the technical scheme of the present invention and should not be construed as limiting the scope of the present invention. All other embodiments, such as modified, modified or simply substituted embodiments, which would be apparent to one of ordinary skill in the art without undue effort based on the examples described below, are intended to be within the scope of the present invention.
In the following examples, kluyveromyces marxianus (Kluyveromyces marxianus) was used from Shanghai pacifying industries, inc.
In the following examples, the amino acid mixtures are conventional commercial products having the following composition: proline 0.6%, threonine 0.6%, methionine 0.7%, isoleucine 0.7%, alanine 0.4%, valine 0.6%, leucine 0.7%, cysteine 1.2%, phenylalanine 0.8%, p-aminobenzoic acid 0.2%, aspartic acid 0.7%, glycine 0.4%, histidine 0.8%, lysine 0.7%, serine 0.5%, tryptophan 1%, tyrosine 0.9%, glutamic acid 0.9%, arginine 0.2%.
Example 1
This example provides a method for converting xylose mother liquor to xylitol by biological fermentation, comprising the steps of:
(1) Carrying out chemical mutagenesis treatment on Kluyveromyces marxianus by adopting nitrosoguanidine to obtain a mutagenized strain;
the specific operation process of the steps is as follows: (1) 50mL of an activation medium (glucose 10g, yeast extract 0.5g, peptone 0.4g, and water was added to a volume of 50 mL) was prepared, and the mixture was placed in a 500mL shaking flask, and sterilized at 115℃for 25 minutes. (2) After the activated medium is cooled, a proper amount of thalli (Kluyveromyces marxianus) is taken and inoculated into a shake flask for culturing for 12 hours at 30 ℃ and 220 r. (3) After the culture is finished, respectively pouring the bacterial liquid into a centrifuge tube after the sterilization treatment, centrifuging for 10min at 12000r, and pouring out the supernatant; then 1mL of sterile water is added into the centrifuge tube with the bacterial precipitation, the mixture is fully mixed and washed, the mixture is centrifuged for 10min at 12000r, the supernatant is poured off, and the washing is repeated twice. (4) Adding 1mL of phosphate buffer solution (pH=6) into the washed thalli, and uniformly mixing to prepare bacterial suspension; then 100uL of nitrosoguanidine solution at 1mg/ml was added to the bacterial suspension, mixed well, and subjected to chemical mutagenesis treatment in a water bath at 37℃for 30min (1 time every 5 minutes).
(2) Performing TC staining treatment on the strain subjected to mutagenesis in the step (1) by adopting 2,3, 5-triphenyltetrazolium chloride, and screening according to a staining result to obtain a colony with vigorous respiratory enzyme activity;
the specific operation process of the steps is as follows: (1) preparing a 2,3, 5-Triphenyl Tetrazolium Chloride (TTC) aqueous solution with the mass concentration of 1%, filtering and sterilizing. 100mL of solid culture medium (15 g of glucose, 0.5g of yeast extract powder and 18g of agar) was prepared, water was added to a volume of 100mL, and the mixture was sterilized at 115℃for 25min. (2) 100uL of TTC aqueous solution is added when the solid medium is cooled to 50 ℃, and after gentle mixing, 4 plates are poured. (3) Gradient dilution of nitrosoguanidine chemically mutagenized bacterial suspension to 10 0 、10 -1 、10 -2 、10 -3 And (4) respectively sucking 200uL of the plates coated with the treatment, culturing for 2 days at the temperature of 30 ℃ in an inverted mode, and selecting a colony with redder color according to the dyeing result to serve as a colony with vigorous respiratory enzyme activity.
(3) Respectively inoculating the bacterial colonies with vigorous respiratory enzyme activity obtained in the step (2) into a screening culture medium containing xylose mother liquor for fermentation culture, measuring the xylitol content and purity in the obtained fermentation liquor after fermentation, and screening according to the content and purity measurement results to obtain the optimal bacterial strain;
the specific operation process of the steps is as follows: preparing solid culture medium (glucose 15g, yeast extract powder 0.5g, agar 18g, adding water and fixing solute 100 mL), subpackaging into test tubes, sterilizing at 115deg.C for 25min, and obliquely standing until the culture medium solidifies. And (3) selecting 20 single colonies which are redder after dyeing in the step (2), respectively named as M-1 to M-20, and culturing the single colonies on a test tube inclined plane in a streak mode for 2 days at the temperature of 30 ℃. Screening by shaking table after culturing, subpackaging screening culture medium (18% xylose mother liquor, 0.5% corn steep liquor dry powder, 0.05% potassium dihydrogen phosphate, 100mL of water-added fixed solute) into triangular flasks with edges, sterilizing each flask at 115 ℃ for 25min, inoculating the M-1-M-20 strain (the inoculation amount is one loop of an inoculating loop) respectively, culturing for 72h at 220r and 30 ℃, and detecting the purity and content of xylitol.
Wherein, the purity test of xylitol adopts HPLC method, HPLC instrument is provided with RID detector, mobile phase is pure water, flow rate is 0.6mL/min, and external standard method is used for quantification. And measuring the content of xylitol, namely measuring the mass content (unit g/100 mL) of dry matters in the solution obtained by fermentation by adopting a refractometer, and multiplying the mass content and the purity of the dry matters to obtain the content of xylitol. For example: 28g/100mL of dry matter of the fermented solution, and the purity of the xylitol is 60%, and the xylitol content in the solution is 28 x 60% = 16.8g/100mL.
The original strain of Kluyveromyces marxianus obtained by purchase was used as an experimental strain (control group), and the measurement results of the content and purity of xylitol obtained after fermentation of each strain are shown in Table 1.
TABLE 1 determination of xylitol content and purity by fermentation of different strains
Sequence number | Experimental strains | M1 | M2 | M3 | M4 | M5 | M6 |
Content g/100mL | 6.99 | 6.47 | 6.4 | 6.75 | 7.35 | 4.71 | 5.48 |
Xylitol purity% | 58.29 | 51.77 | 51.21 | 55.31 | 61.78 | 36.2 | 42.8 |
Sequence number | M7 | M8 | M9 | M10 | M11 | M12 | M13 |
Content g/100mL | 7.72 | 6.85 | 6.68 | 5.93 | 4.66 | 7.22 | 6.83 |
Xylitol purity% | 64.29 | 57.08 | 55.61 | 49.39 | 33.26 | 60.13 | 56.89 |
Sequence number | M14 | M15 | M16 | M17 | M18 | M19 | M20 |
Content g/100mL | 6.54 | 7.20 | 6.68 | 5.64 | 5.80 | 6.00 | 6.53 |
Xylitol purity% | 54.47 | 60.04 | 55.64 | 47.04 | 48.37 | 50.02 | 57.29 |
As can be seen from Table 1, the xylitol has a purity of 58.29% and a content of 6.99g/100mL after fermentation for 72 hours in the experimental strain of the control group; the mutant strain M7 is fermented for 72 hours, the purity of xylitol is 64.29%, and the content of xylitol is 7.72g/100mL, which is obviously improved compared with a control group, so that the mutant strain M7 is used as an optimal strain for subsequent experiments.
(4) And (3) inoculating the optimal strain obtained by screening in the step (3) into a fermentation culture medium containing xylose mother liquor for fermentation culture, and thus, converting the xylose mother liquor into xylitol.
The selection and optimization of the culture of the fermentation medium in step (4) and the determination of the fermentation process parameters are specifically described below.
The fermentation medium is a carrier required by microorganism growth and propagation and biosynthesis of various metabolites, and is mainly a mixture of various nutrients prepared according to a certain proportion. The culture medium suitable for large-scale fermentation can meet the requirements of the most economical synthesis of the product, fewer byproducts, proper raw materials, low cost, stable performance, convenient purchase and transportation and suitability for large-scale storage.
1. Optimization of nitrogen source and nutrient additives selection
The nitrogen source is a nutrient source capable of providing nitrogen elements required by the growth and propagation of microorganisms. As xylitol belongs to a product without N, in theory, the N source only needs to meet the nutrition components required by the growth of thalli, so the invention takes the corn steep liquor dry powder with favorable price as the nitrogen source.
The pathway for the conversion of xylose to xylitol is the isomerisation of xylose to xylulose by the action of Xylose Isomerase (XI) followed by the production of xylitol by the action of xylitol reductase. Vitamin B2 is a prosthetic group of a flavinase that plays a role in hydrogen transfer during the biological redox process. Vitamin B3 is also known as niacin, vitamin B3 is together with tryptophan, which are (NAD + ) Coenzyme I, (NADP) + ) Coenzyme II and its respective reduced form (NAD (P) H) dehydrogenases are also useful for delivering hydrogen ions. The invention aims to strengthen the metabolic pathway of xylitol by adding proper amount of vitamins and amino acids to strengthen the nutritional factors.
The specific tests are shown in Table 2. Wherein, the fermentation medium comprises basic medium and nutrition additive, and basic medium formula is: 20% of xylose mother liquor, 0.5% of corn steep liquor dry powder, 0.5% of urea and 0.025% of monopotassium phosphate, and the solvent is water. Preparing basic culture medium, taking corn steep liquor dry powder 0.5g and urea0.5g, 0.025g of monopotassium phosphate, and 20% xylose mother liquor (dry matter 20g/100mL solution) were added to a volume of 100mL. The primarily selected nutritional additives mainly comprise amino acid mixed solution, choline and VB 2 、VB 3 The specific composition of the fermentation medium is shown in Table 2. When the strain is fermented, the mutagenic strain M7 is inoculated into a fermentation culture medium for fermentation culture, and the M7 seed liquid OD is used for inoculation 600 At 10-15, post-inoculation OD 600 Fermenting and culturing at 220r and 30deg.C under 0.7-1.0. The effect of the above-described nutritional supplements on xylitol content and purity is shown in Table 2. Wherein "/" means that the component is added and "/" means that the component is absent.
TABLE 2 optimization of fermentation Medium formulation results
As is clear from Table 2, 5ml/L of the amino acid mixture and 10mg/L of VB were added to the formulation of the fermentation medium 2 VB at 5mg/L 3 (corresponding to experiment group 14) it was possible to effectively shorten the fermentation period and increase the xylitol content, so that the optimal nutritional supplement composition was determined as follows: amino acid mixture 5mL/L, VB 2 10mg/L、VB 3 5mg/L. Furthermore, it was found by experiment that the addition of choline resulted in a significantly longer fermentation period, and therefore no further choline was added to the nutritional supplement.
2. Initial xylose mother liquor concentration optimization
And respectively preparing xylose mother liquor with concentration of 10%, 15%, 20%, 25% and 30%, performing comparative test, performing shake flask fermentation under the same fermentation conditions, and examining the influence of the xylose mother liquor concentration on xylitol yield. The results are shown in Table 3.
TABLE 3 influence of mother liquor concentration on fermentation effect
The results in Table 3 show that at 25% xylose mother liquor concentration, xylitol content and conversion were higher and overall cost was lowest.
3. Fermentation process optimization
3.1 control of fermentation temperature
The experiment examined the effect of fermentation temperature on xylitol production: the same fermentation medium is adopted, other fermentation conditions are the same, shake flask fermentation is respectively carried out at 28 ℃,30 ℃, 33 ℃ and 35 ℃, the influence of the fermentation temperature on the xylitol yield is examined, and the result shows that the fermentation temperature has the best effect at 30 ℃.
3.2 control of fermentation broth pH
The experiment examined the effect of the initial pH of the fermentation medium on xylitol production: the same fermentation medium is adopted, other fermentation conditions are kept the same, initial pH values are respectively adjusted to 5.0, 5.5, 6.0, 6.5 and 7.0, shake flask fermentation is carried out, the influence of different initial pH values on xylitol yield is examined, and the result shows that the fermentation pH values are basically consistent in effect and superior to 5.0 and 7.0 at 5.5, so that the preferable fermentation pH value range is 5.5-6.5.
3.3 Effect of inoculum size on fermentation
The effect of inoculum size on xylitol production was examined in this experiment: the same fermentation medium is adopted, other fermentation conditions are the same, liquid seeds of M7 mutagenesis strains are respectively inoculated according to inoculum sizes of 5%, 10% and 15% (V/V), the influence of different inoculum sizes on xylitol yield is examined, and the result shows that the fermentation result is the best when the inoculum size is 15%.
Therefore, in the optimized fermentation medium, the basic medium consists of the following components in parts by mass: 25% of xylose mother liquor, 0.5% of corn steep liquor dry powder, 0.5% of urea and 0.025% of monopotassium phosphate, and the solvent is water; the composition of the nutritional supplement, based on the final concentration in the basal medium, is: amino acid mixture 5mL/L, VB 2 10mg/L、VB 3 5mg/L. The conditions of fermentation culture are as follows: 200-300 rpm, 28-33 DEG CAnd (3) performing activation culture for 70-80 h under the pH condition of 5.5-6.5. The inoculation amount of the optimal strain is 15% V/V during fermentation culture.
In summary, the method for converting xylose mother liquor into xylitol through biological fermentation provided by the invention uses Kluyveromyces marxianus as a fermentation strain, and firstly uses nitrosoguanidine to mutagenize the strain to obtain a base mutant strain; then, a TC staining method is adopted for screening to obtain strains with vigorous respiratory enzyme activity, so that blindness of common screening is reduced; finally, according to the way of converting xylose into xylitol, the conversion of xylose into xylitol can be further promoted by adding the amino acid mixture and the vitamins. The method not only omits the xylose purification step, but also simplifies the xylitol separation step, can effectively reduce the production cost of the xylitol, and has the advantages of higher content and purity of the xylitol in the obtained product, simple, safe and energy-saving production process, and good application prospect in the fields of reuse of xylose mother liquor and production of the xylitol.
Claims (10)
1. A method for converting xylose mother liquor to xylitol by biological fermentation, comprising the steps of:
(1) Carrying out chemical mutagenesis treatment on Kluyveromyces marxianus by adopting nitrosoguanidine to obtain a mutagenized strain;
(2) Dyeing the strain subjected to mutagenesis in the step (1) by adopting 2,3, 5-triphenyltetrazolium chloride, and screening according to a dyeing result to obtain a colony with vigorous respiratory enzyme activity;
(3) Respectively inoculating the colonies with vigorous respiratory enzyme activity obtained in the step (2) into a screening culture medium containing xylose mother liquor for culture, measuring the xylitol content and purity in the obtained fermentation liquor after fermentation, and screening according to the content and purity measurement results to obtain the optimal strain;
(4) And (3) inoculating the optimal strain obtained by screening in the step (3) into a fermentation culture medium containing xylose mother liquor for fermentation culture, and thus, converting the xylose mother liquor into xylitol.
2. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1, wherein in step (1), the chemical mutagenesis treatment is to add 0.8-1.2 mg/mL nitrosoguanidine solution into the bacterial suspension of kluyveromyces marxianus, and treat in water bath at 35-40 ℃ for 20-40 min.
3. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1 or 2, wherein in step (1), the kluyveromyces marxianus is previously subjected to an activation treatment; the activation treatment is to inoculate Kluyveromyces marxianus into an activation culture medium, and perform activation culture for 10-15 h at the temperature of 28-32 ℃ at 200-300 rpm; the composition of the activation medium is as follows: glucose 9-12 g, yeast extract 0.3-0.7 g, peptone 0.3-0.5 g, and water to constant volume to 50mL.
4. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1, wherein in step (2), the dyeing treatment is carried out after mixing an aqueous solution of 2,3, 5-triphenyltetrazolium chloride with a bacterial suspension of the strain after mutagenesis; the dyeing treatment time is 1-3 d; the mass concentration of the 2,3, 5-triphenyl tetrazolium chloride aqueous solution is 0.8% -1.2%.
5. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1, wherein in step (3), the screening medium consists of the following components in parts by mass: 16 to 20 percent of xylose mother liquor, 0.3 to 0.8 percent of corn steep liquor dry powder, 0.03 to 0.08 percent of monopotassium phosphate and water as solvent.
6. The method for converting xylose mother liquor to xylitol by biological fermentation according to claim 1, wherein in step (3), the conditions of said cultivation are: culturing at 200-300 rpm and 28-33 deg.c for 70-80 hr.
7. The passliving being according to claim 1A method for converting xylose mother liquor into xylitol by fermentation, which is characterized in that in the step (4), the fermentation medium consists of a basic medium and nutrition additives; the basic culture medium consists of the following components in parts by mass: 23 to 28 percent of xylose mother liquor, 0.3 to 0.8 percent of corn steep liquor dry powder, 0.4 to 0.6 percent of urea, 0.02 to 0.05 percent of monopotassium phosphate and water as solvent; the composition of the nutritional supplement, based on the final concentration in the basal medium, is: amino acid mixed solution 4-6 mL/L, VB 2 8~12mg/L、VB 3 4~6mg/L。
8. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 7, wherein the basic culture medium consists of the following components in parts by mass: 25% of xylose mother liquor, 0.5% of corn steep liquor dry powder, 0.5% of urea and 0.025% of monopotassium phosphate, and the solvent is water; the composition of the nutritional supplement, based on the final concentration in the basal medium, is: amino acid mixture 5mL/L, VB 2 10mg/L、VB 3 5mg/L。
9. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1, wherein in step (4), the conditions of the fermentation culture are: fermenting and culturing at 200-300 rpm, 28-33 deg.c and pH of 5.5-6.5 for 70-80 hr.
10. The method for converting xylose mother liquor into xylitol by biological fermentation according to claim 1, wherein in step (4), the inoculation amount of the optimal strain is 13% -17% V/V during the fermentation culture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311681748.8A CN117646040A (en) | 2023-12-08 | 2023-12-08 | Method for converting xylose mother liquor into xylitol through biological fermentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311681748.8A CN117646040A (en) | 2023-12-08 | 2023-12-08 | Method for converting xylose mother liquor into xylitol through biological fermentation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117646040A true CN117646040A (en) | 2024-03-05 |
Family
ID=90043123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311681748.8A Pending CN117646040A (en) | 2023-12-08 | 2023-12-08 | Method for converting xylose mother liquor into xylitol through biological fermentation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117646040A (en) |
-
2023
- 2023-12-08 CN CN202311681748.8A patent/CN117646040A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109439701B (en) | Method for preparing ergothioneine by biosynthesis and fermentation medium | |
CN105112476B (en) | Method for producing lipopeptide biosurfactant by fermentation | |
US20240102058A1 (en) | Caproate-producing bacterium with multiple substrate utilization capabilities and its applications | |
CN101173240A (en) | Method for producing D-lactic acid and brood-cell lactobacillus special for the same | |
CN113321580B (en) | Method for producing malic acid | |
CN113637607B (en) | Amycolatopsis and application thereof | |
CN116333948B (en) | Clostridium aerophilum enrichment medium and preparation method thereof | |
CN115895976B (en) | Escherichia coli for producing L-tryptophan and application thereof in producing L-tryptophan | |
CN117646040A (en) | Method for converting xylose mother liquor into xylitol through biological fermentation | |
CN110527650A (en) | A kind of Selective medium and its application | |
CN107326052B (en) | Method for improving glutamate decarboxylase activity by using D101 macroporous adsorption resin | |
CN106591401B (en) | Fermentation promoter for increasing yield of gentamicin C1a and addition method thereof | |
CN116515651A (en) | Saccharomycetes glaucocalus tectorial membrane yeast strain and application thereof in yellow wine brewing | |
CN114634952A (en) | Method for improving erythritol yield and sugar alcohol conversion rate | |
CN113502306A (en) | Method for producing sclareolide by catalyzing sclareol | |
CN112852896A (en) | Fermentation production method of L-arginine | |
WO2019144920A1 (en) | Method for promoting synthesis of sorbitol dehydrogenase and coenzyme pyrroloquinoline from gluconobacter oxydans | |
CN110982716B (en) | Strain for producing natural tyrosol and preparation method of natural tyrosol | |
CN111424061A (en) | Rhodococcus ruber and method for producing nicotinamide by using same | |
CN114395494B (en) | Saberlin Dener yeast T52 and application thereof | |
CN116042731B (en) | Method for producing 1, 3-propylene glycol by using distillers' grains enzymolysis liquid | |
CN118374369B (en) | Kluyveromyces marxianus and application thereof | |
CN109811017B (en) | Fermentation method for producing EPA (eicosapentaenoic acid) by using mortierella alpina based on dissolved oxygen and pH regulation | |
CN117625706A (en) | Method for improving fermentation yield of L-proline | |
CN118667892A (en) | Method for converting xylose into xylitol by utilizing saccharomycetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |